Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

634.63 22.14 −3.37%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a

Medpace Holdings, Inc. (MEDP) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Medpace Holdings, Inc. (MEDP) trades at a EV/FCF of 25.7×. Over the past ten years it has ranged from 11.7× (March 2020) to 31.7× (March 2024); the current reading is higher than 93% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 23.2× 36.47%
FY2024 17.0× (27.13%)
FY2023 23.3× 20.05%
FY2022 19.4× (38.41%)
FY2021 31.5× 50.85%
FY2020 20.9× 30.37%
FY2019 16.0× 13.94%
FY2018 14.1× (27.88%)
FY2017 19.5× 6.27%
FY2016 18.4× 23.51%

Quarterly newest first

Period EV/FCF Change
Sep 2026 25.2× 22.73%
Jun 2026 20.6× 11.44%
Mar 2026 18.4× (20.46%)
Dec 2025 23.2× 9.83%
40 more quarters

Against its own ten years

Low 11.7× High 31.7×
Ten-year median 19.5×
Current reading's percentile 93

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on MEDP